Penumbra stock gapped up Wednesday after the medtech company beat fourth-quarter expectations, though its revenue guidance came in shy. Shares of medical device company Penumbra (NYSE:PEN) jumped ...
Expert Rev Cardiovasc Ther. 2009;7(1):29-48. Several additional trials are using identification of a penumbra by neuroimaging for the inclusion of patients. The ReoPro Retavase Reperfusion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback